Candriam Luxembourg S.C.A. lifted its holdings in Cigna Corporation (NYSE:CI) by 243.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 60,645 shares of the health services provider’s stock after buying an additional 42,987 shares during the period. Candriam Luxembourg S.C.A.’s holdings in Cigna Corporation were worth $11,337,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also bought and sold shares of CI. JPMorgan Chase & Co. lifted its stake in shares of Cigna Corporation by 40.8% in the second quarter. JPMorgan Chase & Co. now owns 4,088,728 shares of the health services provider’s stock worth $684,413,000 after buying an additional 1,184,632 shares in the last quarter. FMR LLC lifted its stake in shares of Cigna Corporation by 6.7% in the second quarter. FMR LLC now owns 6,909,638 shares of the health services provider’s stock worth $1,156,604,000 after buying an additional 432,978 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in shares of Cigna Corporation by 4,082.8% in the second quarter. Arrowstreet Capital Limited Partnership now owns 438,231 shares of the health services provider’s stock worth $73,355,000 after buying an additional 427,754 shares in the last quarter. Vanguard Group Inc. lifted its stake in shares of Cigna Corporation by 2.5% in the second quarter. Vanguard Group Inc. now owns 17,130,735 shares of the health services provider’s stock worth $2,867,514,000 after buying an additional 424,469 shares in the last quarter. Finally, American Century Companies Inc. lifted its stake in shares of Cigna Corporation by 56.9% in the second quarter. American Century Companies Inc. now owns 1,140,341 shares of the health services provider’s stock worth $190,882,000 after buying an additional 413,759 shares in the last quarter. 88.16% of the stock is currently owned by hedge funds and other institutional investors.

In related news, Chairman Isaiah Harris, Jr. sold 247 shares of Cigna Corporation stock in a transaction that occurred on Tuesday, September 12th. The shares were sold at an average price of $185.27, for a total value of $45,761.69. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Lisa R. Bacus sold 2,236 shares of Cigna Corporation stock in a transaction that occurred on Wednesday, August 16th. The shares were sold at an average price of $179.95, for a total transaction of $402,368.20. Following the completion of the transaction, the executive vice president now owns 18,501 shares of the company’s stock, valued at approximately $3,329,254.95. The disclosure for this sale can be found here. Insiders sold 3,715 shares of company stock valued at $678,797 in the last 90 days. Company insiders own 1.30% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Candriam Luxembourg S.C.A. Boosts Stake in Cigna Corporation (CI)” was first reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another domain, it was stolen and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.watchlistnews.com/candriam-luxembourg-s-c-a-boosts-stake-in-cigna-corporation-ci/1695546.html.

Cigna Corporation (NYSE:CI) traded up $0.46 during trading on Friday, hitting $197.98. 991,077 shares of the stock were exchanged, compared to its average volume of 1,607,644. The stock has a market cap of $48,698.50, a P/E ratio of 19.03, a price-to-earnings-growth ratio of 1.51 and a beta of 0.49. Cigna Corporation has a twelve month low of $131.03 and a twelve month high of $206.45. The company has a quick ratio of 0.39, a current ratio of 0.39 and a debt-to-equity ratio of 0.37.

Cigna Corporation (NYSE:CI) last released its quarterly earnings results on Thursday, November 2nd. The health services provider reported $2.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.36 by $0.47. The business had revenue of $10.38 billion for the quarter, compared to the consensus estimate of $10.17 billion. Cigna Corporation had a net margin of 5.74% and a return on equity of 18.85%. The business’s revenue was up 5.1% on a year-over-year basis. During the same period in the previous year, the firm earned $1.94 EPS. equities research analysts forecast that Cigna Corporation will post 10.34 earnings per share for the current year.

CI has been the topic of a number of analyst reports. Jefferies Group LLC lifted their target price on shares of Cigna Corporation from $221.00 to $231.00 and gave the stock a “buy” rating in a research note on Friday, November 3rd. Zacks Investment Research raised shares of Cigna Corporation from a “hold” rating to a “buy” rating and set a $214.00 target price on the stock in a research note on Monday, October 9th. BMO Capital Markets initiated coverage on shares of Cigna Corporation in a research note on Monday, October 16th. They set a “market perform” rating and a $210.00 target price on the stock. Citigroup Inc. lifted their target price on shares of Cigna Corporation from $198.00 to $231.00 and gave the stock a “buy” rating in a research note on Friday, November 3rd. Finally, BidaskClub downgraded shares of Cigna Corporation from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Three research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $201.50.

Cigna Corporation Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.